Pharmacokinetic Profile of Matrine in Pigs Following Intravenous and Oral Administration
Veterinary Sciences · 03.07.2026 · 13 (7) · 652
DOI: 10.3390/vetsci13070652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Sciences, online erschienen am 03.07.2026. Verfasst von Jianzhong Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Laboratory of Veterinary Public Health and Safety, Shanxi Scholarship Council of China, Fundamental Research Program of Shanxi Province.
Abstract (Originalsprache)
The search for effective alternatives or adjuncts to conventional anti-infective strategies in food animals has increased interest in plant-derived bioactive compounds. Matrine, a quinolizidine alkaloid derived from Sophora flavescens, has attracted considerable attention because of its broad bioactivities and potential veterinary relevance. Recent oral pharmacokinetic and intestinal-lumen PBPK studies in pigs have begun to emerge; however, currently available swine data remain largely confined to oral exposure-oriented experiments and do not permit direct route comparison or estimation of absolute oral bioavailability. In the present study, the plasma pharmacokinetics of matrine in pigs were evaluated after single-dose intravenous and oral administration. Twelve healthy piglets received matrine at 8 mg/kg body weight via either the intravenous or oral route, and plasma concentrations were quantified using a validated UPLC–MS/MS method. Pharmacokinetic parameters were estimated by non-compartmental analysis. Compared with intravenous administration, oral dosing produced lower observed exposure based on AUC0−t and a lower peak plasma concentration, with AUC0−t and Cmax values of 418.94 ± 75.52 h·ng/mL and 66.24 ± 8.44 ng/mL, respectively, versus 558.01 ± 59.57 h·ng/mL and 224.64 ± 20.94 ng/mL after intravenous administration. Oral administration was associated with a Tmax of 2.49 ± 0.02 h and a longer apparent terminal half-life and mean residence time than intravenous dosing. These findings provide pharmacokinetic evidence to support future route selection, dosing-regimen design, and PK/PD-based dose optimization of matrine in pigs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanxi Key Laboratory for Modernization of TCVM, College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China.
ORCID-Profile: Jianzhong Wang, Zhenbiao Zhang
Förderung
- State Key Laboratory of Veterinary Public Health and Safety
- Shanxi Scholarship Council of China
- Fundamental Research Program of Shanxi Province
Zitieren
APA
Wang, J., Yan, H., Liu, J., Zhou, R., Yin, W., Zhong, J., Sun, P., Sun, N., Zhang, Z., Sun, Y., Yang, H., Fan, K., & Li, H. (2026). Pharmacokinetic Profile of Matrine in Pigs Following Intravenous and Oral Administration. Veterinary Sciences, 13(7), 652. https://doi.org/10.3390/vetsci13070652
Vancouver
Wang J, Yan H, Liu J, Zhou R, Yin W, Zhong J, et al. Pharmacokinetic Profile of Matrine in Pigs Following Intravenous and Oral Administration. Veterinary Sciences. 2026;13(7):652. doi:10.3390/vetsci13070652
BibTeX
@article{Wang2026,
author = {Wang, Jianzhong and Yan, Hang and Liu, Jing and Zhou, Rui and Yin, Wei and Zhong, Jia and Sun, Panpan and Sun, Na and Zhang, Zhenbiao and Sun, Yaogui and Yang, Huizhen and Fan, Kuohai and Li, Hongquan},
title = {Pharmacokinetic Profile of Matrine in Pigs Following Intravenous and Oral Administration},
journal = {Veterinary Sciences},
year = {2026},
volume = {13},
number = {7},
pages = {652},
doi = {10.3390/vetsci13070652}
}
EUVIMED